Speciality

CPT Code

Description

Proprietary Laboratory Analyses

0521U

Rheumatoid factor IgA and IgM, cyclic citrullinated peptide (CCP) antibodies, and scavenger receptor A (SR-A) by immunoassay, blood

Proprietary Laboratory Analyses

0522U

Carbonic anhydrase VI, parotid specific/secretory protein and salivary protein 1 (SP1), IgG, IgM, and IgA antibodies, chemiluminescence, semiqualitative, blood

Proprietary Laboratory Analyses

0523U

Oncology (solid tumor), DNA, qualitative, next-generation sequencing (NGS) of single-nucleotide variants (SNV) and insertion/deletions in 22 genes utilizing formalin-fixed paraffin-embedded tissue, reported as presence or absence of mutation(s), location of mutation(s), nucleotide change, and amino acid change

Proprietary Laboratory Analyses

0524U

Obstetrics (preeclampsia), sFlt-1/PlGF ratio, immunoassay, utilizing serum or plasma, reported as a value

Proprietary Laboratory Analyses

0525U

Oncology, spheroid cell culture, 11-drug panel (carboplatin, docetaxel, doxorubicin, etoposide, gemcitabine, niraparib, olaparib, paclitaxel, rucaparib, topotecan, veliparib) ovarian, fallopian, or peritoneal response prediction for each drug

Proprietary Laboratory Analyses

0526U

Nephrology (renal transplant), quantification of CXCL10 chemokines, flow cytometry, urine, reported as pg/mL creatinine baseline and monitoring over time

Proprietary Laboratory Analyses

0527U

Herpes simplex virus (HSV) types 1 and 2 and Varicella zoster virus (VZV), amplified probe technique, each pathogen reported as detected or not detected

Proprietary Laboratory Analyses

0528U

Lower respiratory tract infectious agent detection, 18 bacteria, 8 viruses, and 7 antimicrobial-resistance genes, amplified probe technique, including reverse transcription for RNA targets, each analyte reported as detected or not detected with semiquantitative results for 15 bacteria

Proprietary Laboratory Analyses

0529U

Hematology (venous thromboembolism [VTE]), genome-wide single-nucleotide polymorphism variants, including F2 and F5 gene analysis, and Leiden variant, by microarray analysis, saliva, report as risk score for VTE

Proprietary Laboratory Analyses

0530U

Oncology (pan-solid tumor), ctDNA, utilizing plasma, next-generation sequencing (NGS) of 77 genes, 8 fusions, microsatellite instability, and tumor mutation burden, interpretative report for single-nucleotide variants, copy-number alterations, with therapy association

Category III

0901T

Placement of bone marrow sampling port, including imaging guidance when performed

Category III

0902T

QTc interval derived by augmentative algorithmic analysis of input from an external, patient-activated mobile ECG device

Category III

0903T

Electrocardiogram, algorithmically generated 12-lead ECG from a reduced-lead ECG; with interpretation and report

Category III

0904T

Electrocardiogram, algorithmically generated 12-lead ECG from a reduced-lead ECG; tracing only

Category III

0905T

Electrocardiogram, algorithmically generated 12-lead ECG from a reduced-lead ECG; interpretation and report only

Category III

0906T

Concurrent optical and magnetic stimulation (COMS) therapy, wound assessment and dressing care; first application, total wound(s) surface area less than or equal to 50 sq cm

Category III

0907T

Concurrent optical and magnetic stimulation (COMS) therapy, wound assessment and dressing care; each additional application, total wound(s) surface area less than or equal to 50 sq cm (List separately in addition to code for primary procedure)

Category III

0908T

Open implantation of integrated neurostimulation system, vagus nerve, including analysis and programming, when performed

Category III

0909T

Replacement of integrated neurostimulation system, vagus nerve, including analysis and programming, when performed

Category III

0910T

Removal of integrated neurostimulation system, vagus nerve

Category III

0911T

Electronic analysis of implanted integrated neurostimulation system, vagus nerve; without programming by physician or other qualified health care professional

Category III

0912T

Electronic analysis of implanted integrated neurostimulation system, vagus nerve; with simple programming by physician or other qualified health care professional

Category III

0913T

Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon (eg, drug-coated, drug- eluting), including mechanical dilation by nondrug-delivery balloon angioplasty, endoluminal imaging using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) when performed, imaging supervision, interpretation, and report, single major coronary artery or branch

Category III

0914T

Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon (eg, drug-coated, drug- eluting) performed on a separate target lesion from the target lesion treated with balloon angioplasty, coronary stent placement or coronary atherectomy, including mechanical dilation by nondrug-delivery balloon angioplasty, endoluminal imaging using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) when performed, imaging supervision, interpretation, and report, single major coronary artery or branch (List separately in addition to code for percutaneous coronary stent or atherectomy intervention)

Speciality

CPT Code

Description

Category III

0915T

Insertion of permanent cardiac contractility modulation-defibrillation system component(s), including fluoroscopic guidance, and evaluation and programming of sensing and therapeutic parameters; pulse generator and dual transvenous electrodes/leads (pacing and defibrillation)

Category III

0916T

Insertion of permanent cardiac contractility modulation-defibrillation system component(s), including fluoroscopic guidance, and evaluation and programming of sensing and therapeutic parameters; pulse generator only

Category III

0917T

Insertion of permanent cardiac contractility modulation-defibrillation system component(s), including fluoroscopic guidance, and evaluation and programming of sensing and therapeutic parameters; single transvenous lead (pacing or defibrillation) only

Category III

0918T

Insertion of permanent cardiac contractility modulation-defibrillation system component(s), including fluoroscopic guidance, and evaluation and programming of sensing and therapeutic parameters; dual transvenous leads (pacing and defibrillation) only

Category III

0919T

Removal of a permanent cardiac contractility modulation-defibrillation system component(s); pulse generator only

Category III

0920T

Removal of a permanent cardiac contractility modulation-defibrillation system component(s); single transvenous pacing lead only

Category III

0921T

Removal of a permanent cardiac contractility modulation-defibrillation system component(s); single transvenous defibrillation lead only

Category III

0922T

Removal of a permanent cardiac contractility modulation-defibrillation system component(s); dual (pacing and defibrillation) transvenous leads only

Category III

0923T

Removal and replacement of permanent cardiac contractility modulation-defibrillation pulse generator only

Category III

0924T

Repositioning of previously implanted cardiac contractility modulation-defibrillation transvenous electrode(s)/lead(s), including fluoroscopic guidance and programming of sensing and therapeutic parameters

Category III

0925T

Relocation of skin pocket for implanted cardiac contractility modulation-defibrillation pulse generator

Category III

0926T

Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, including review and report, implantable cardiac contractility modulation-defibrillation system

Category III

0927T

Interrogation device evaluation (in person) with analysis, review, and report, including connection, recording, and disconnection, per patient encounter, implantable cardiac contractility modulation-defibrillation system

Category III

0928T

Interrogation device evaluation (remote), up to 90 days, cardiac contractility modulation-defibrillation system with interim analysis and report(s) by a physician or other qualified health care professional

Category III

0929T

Interrogation device evaluation (remote), up to 90 days, cardiac contractility modulation-defibrillation system, remote data acquisition(s), receipt of transmissions, technician review, technical support, and distribution of results

Category III

0930T

Electrophysiologic evaluation of cardiac contractility modulation-defibrillator leads, including defibrillation-threshold evaluation (induction of arrhythmia, evaluation of sensing and therapy for arrhythmia termination), at time of initial implantation or replacement with testing of cardiac contractility modulation-defibrillator pulse generator

Category III

0931T

Electrophysiologic evaluation of cardiac contractility modulation-defibrillator leads, including defibrillation-threshold evaluation (induction of arrhythmia, evaluation of sensing and therapy for arrhythmia termination), separate from initial implantation or replacement with testing of cardiac contractility modulation-defibrillator pulse generator

Category III

0932T

Noninvasive detection of heart failure derived from augmentative analysis of an echocardiogram that demonstrated preserved ejection fraction, with interpretation and report by a physician or other qualified health care professional

Category III

0933T

Transcatheter implantation of wireless left atrial pressure sensor for long-term left atrial pressure monitoring, including sensor calibration and deployment, right heart catheterization, transseptal puncture, imaging guidance, and radiological supervision and interpretation

Category III

0934T

Remote monitoring of a wireless left atrial pressure sensor for up to 30 days, including data from daily uploads of left atrial pressure recordings, interpretation(s) and trend analysis, with adjustments to the diuretics plan, treatment paradigm thresholds, medications or lifestyle modifications, when performed, and report(s) by a physician or other qualified health care professional

Category III

0935T

Cystourethroscopy with renal pelvic sympathetic denervation, radiofrequency ablation, retrograde ureteral approach, including insertion of guide wire, selective placement of ureteral sheath(s) and multiple conformable electrodes, contrast injection(s), and fluoroscopy, bilateral

Category III

0936T

Photobiomodulation therapy of retina, single session

Category III

0937T

External electrocardiographic recording for greater than 15 days up to 30 days by continuous rhythm recording and storage; including recording, scanning analysis with report, review and interpretation by a physician or other qualified health care professional

Category III

0938T

External electrocardiographic recording for greater than 15 days up to 30 days by continuous rhythm recording and storage; recording (including connection and initial recording)

Category III

0939T

External electrocardiographic recording for greater than 15 days up to 30 days by continuous rhythm recording and storage; scanning analysis with report

Category III

0940T

External electrocardiographic recording for greater than 15 days up to 30 days by continuous rhythm recording and storage; review and interpretation by a physician or other qualified health care professional

Category III

0941T

Cystourethroscopy, flexible; with insertion and expansion of prostatic urethral scaffold using integrated cystoscopic visualization

Category III

0942T

Cystourethroscopy, flexible; with removal and replacement of prostatic urethral scaffold

Category III

0943T

Cystourethroscopy, flexible; with removal of prostatic urethral scaffold

Speciality

CPT Code

Description

Category III

0944T

3D contour simulation of target liver lesion(s) and margin(s) for image-guided percutaneous microwave ablation

Category III

0945T

Intraoperative assessment for abnormal (tumor) tissue, in-vivo, following partial mastectomy (eg, lumpectomy) using computer-aided fluorescence imaging (List separately in addition to code for primary procedure)

Category III

0946T

Orthopedic implant movement analysis using paired computed tomography (CT) examination of the target structure, including data acquisition, data preparation and transmission, interpretation and report (including CT scan of the joint or extremity performed with paired views)

Category III

0947T

Magnetic resonance image guided low intensity focused ultrasound (MRgFUS), stereotactic blood-brain barrier disruption using microbubble resonators to increase the concentration of blood-based biomarkers of target, intracranial, including stereotactic navigation and frame placement, when performed

Category III

0863T

Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; transmitter component only

Category III

0864T

Low-intensity extracorporeal shock wave therapy involving corpus cavernosum, low energy

Category III

0865T

Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion identification, characterization, and quantification, with brain volume(s) quantification and/ or severity score, when performed, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the brain during the same session

Category III

0866T

Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion detection, characterization, and quantification, with brain volume(s) quantification and/or severity score, when performed, data preparation and transmission, interpretation and report, obtained with diagnostic MRI examination of the brain (List separately in addition to code for primary procedure)

Integumentary System

15011

Harvest of skin for skin cell suspension autograft; first 25 sq cm or less

Integumentary System

15012

Harvest of skin for skin cell suspension autograft; each additional 25 sq cm or part thereof (List separately in addition to code for primary procedure)

Integumentary System

15013

Preparation of skin cell suspension autograft, requiring enzymatic processing, manual mechanical disaggregation of skin cells, and filtration; first 25 sq cm or less of harvested skin

Integumentary System

15014

Preparation of skin cell suspension autograft, requiring enzymatic processing, manual mechanical disaggregation of skin cells, and filtration; each additional 25 sq cm of harvested skin or part thereof (List separately in addition to code for primary procedure)

Integumentary System

15015

Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, trunk, arms, legs; first 480 sq cm or less

Integumentary System

15016

Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, trunk, arms, legs; each additional 480 sq cm or part thereof (List separately in addition to code for primary procedure)

Integumentary System

15017

Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 480 sq cm or less

Integumentary System

15018

Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; each additional 480 sq cm or part thereof (List separately in addition to code for primary procedure)

Musculoskeletal System

25448

Arthroplasty, intercarpal or carpometacarpal joints; suspension, including transfer or transplant of tendon, with interposition, when performed

Cardiovascular System

38225

Chimeric antigen receptor T-cell (CAR-T) therapy; harvesting of blood-derived T lymphocytes for development of genetically modified autologous CAR-T cells, per day

Cardiovascular System

38226

Chimeric antigen receptor T-cell (CAR-T) therapy; preparation of blood-derived T lymphocytes for transportation (eg, cryopreservation, storage)

Cardiovascular System

38227

Chimeric antigen receptor T-cell (CAR-T) therapy; receipt and preparation of CAR-T cells for administration

Cardiovascular System

38228

Chimeric antigen receptor T-cell (CAR-T) therapy; CAR-T cell administration, autologous

Digestive System

49186

Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 5 cm or less

Digestive System

49187

Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 5.1 to 10 cm

Digestive System

49188

Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 10.1 to 20 cm

Digestive System

49189

Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 20.1 to 30 cm

Digestive System

49190

Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); greater than 30 cm

Speciality

CPT Code

Description

Genital Urinary System

51721

Insertion of transurethral ablation transducer for delivery of thermal ultrasound for prostate tissue ablation, including suprapubic tube placement during the same session and placement of an endorectal cooling device, when performed

Genital Urinary System

53865

Cystourethroscopy with insertion of temporary device for ischemic remodeling (ie, pressure necrosis) of bladder neck and prostate

Genital Urinary System

53866

Catheterization with removal of temporary device for ischemic remodeling (ie, pressure necrosis) of bladder neck and prostate

Genital Urinary System

55881

Ablation of prostate tissue, transurethral, using thermal ultrasound, including magnetic resonance imaging guidance for, and monitoring of, tissue ablation

Genital Urinary System

55882

Ablation of prostate tissue, transurethral, using thermal ultrasound, including magnetic resonance imaging guidance for, and monitoring of, tissue ablation; with insertion of transurethral ultrasound transducer for delivery of thermal ultrasound, including suprapubic tube placement and placement of an endorectal cooling device, when performed

Nervous System

60660

Ablation of 1 or more thyroid nodule(s), one lobe or the isthmus, percutaneous, including imaging guidance, radiofrequency

Nervous System

60661

Ablation of 1 or more thyroid nodule(s), additional lobe, percutaneous, including imaging guidance, radiofrequency (List separately in addition to code for primary procedure)

Nervous System

61715

Magnetic resonance image guided high intensity focused ultrasound (MRgFUS), stereotactic ablation of target, intracranial, including stereotactic navigation and frame placement, when performed

Nervous System

64466

Thoracic fascial plane block, unilateral; by injection(s), including imaging guidance, when performed

Nervous System

64467

Thoracic fascial plane block, unilateral; by continuous infusion(s), including imaging guidance, when performed

Nervous System

64468

Thoracic fascial plane block, bilateral; by injection(s), including imaging guidance, when performed

Nervous System

64469

Thoracic fascial plane block, bilateral; by continuous infusion(s), including imaging guidance, when performed

Nervous System

64473

Lower extremity fascial plane block, unilateral; by injection(s), including imaging guidance, when performed

Nervous System

64474

Lower extremity fascial plane block, unilateral; by continuous infusion(s), including imaging guidance, when performed

Nervous System

66683

Implantation of iris prosthesis, including suture fixation and repair or removal of iris, when performed

Radiology

76014

MR safety implant and/or foreign body assessment by trained clinical staff, including identification and verification of implant components from appropriate sources (eg, surgical reports, imaging reports, medical device databases, device vendors, review of prior imaging), analyzing current MR conditional status of individual components and systems, and consulting published professional guidance with written report; initial 15 minutes

Radiology

76015

MR safety implant and/or foreign body assessment by trained clinical staff, including identification and verification of implant components from appropriate sources (eg, surgical reports, imaging reports, medical device databases, device vendors, review of prior imaging), analyzing current MR conditional status of individual components and systems, and consulting published professional guidance with written report; each additional 30 minutes (List separately in addition to code for primary procedure)

Radiology

76016

MR safety determination by a physician or other qualified health care professional responsible for the safety of the MR procedure, including review of implant MR conditions for indicated MR examination, analysis of risk vs clinical benefit of performing MR examination, and determination of MR equipment, accessory equipment, and expertise required to perform examination, with written report

Radiology

76017

MR safety medical physics examination customization, planning and performance monitoring by medical physicist or MR safety expert, with review and analysis by physician or other qualified health care professional to prioritize and select views and imaging sequences, to tailor MR acquisition specific to restrictive requirements or artifacts associated with MR conditional implants or to mitigate risk of non-conditional implants or foreign bodies, with written report

Radiology

76018

MR safety implant electronics preparation under supervision of physician or other qualified health care professional, including MR-specific programming of pulse generator and/or transmitter to verify device integrity, protection of device internal circuitry from MR electromagnetic fields, and protection of patient from risks of unintended stimulation or heating while in the MR room, with written report

Radiology

76019

MR safety implant positioning and/or immobilization under supervision of physician or other qualified health care professional, including application of physical protections to secure implanted medical device from MR-induced translational or vibrational forces, magnetically induced functional changes, and/or prevention of radiofrequency burns from inadvertent tissue contact while in the MR room, with written report

Radiology

76989

Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; interpretation and report only

Pathology and Laboratory

81195

Cytogenomic (genome-wide) analysis, hematologic malignancy, structural variants and copy number variants, optical genome mapping (OGM)

Speciality

CPT Code

Description

Pathology and Laboratory

81515

Infectious disease, bacterial vaginosis and vaginitis, real-time PCR amplification of DNA markers for Atopobium vaginae, Atopobium species, Megasphaera type 1, and Bacterial Vaginosis Associated Bacteria-2 (BVAB-2), utilizing vaginal-

fluid specimens, algorithm reported as positive or negative for high likelihood of bacterial vaginosis, includes separate detection of Trichomonas vaginalis and Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata/Candida krusei, when reported

Pathology and Laboratory

81558

Transplantation medicine (allograft rejection, kidney), mRNA, gene expression profiling by quantitative polymerase chain reaction (qPCR) of 139 genes, utilizing whole blood, algorithm reported as a binary categorization as transplant excellence, which indicates immune quiescence, or not transplant excellence, indicating subclinical rejection

Pathology and Laboratory

82233

Beta-amyloid; 1-40 (Abeta 40)

Pathology and Laboratory

82234

Beta-amyloid; 1-42 (Abeta 42)

Pathology and Laboratory

83884

Neurofilament light chain (NfL)

Pathology and Laboratory

84393

Tau, phosphorylated (eg, pTau 181, pTau 217), each

Pathology and Laboratory

84394

Tau, total (tTau)

Pathology and Laboratory

86581

Streptococcus pneumoniae antibody (IgG), serotypes, multiplex immunoassay, quantitative

Pathology and Laboratory

87513

Infectious agent detection by nucleic acid (DNA or RNA); Helicobacter pylori (H. pylori), clarithromycin resistance, amplified probe technique

Pathology and Laboratory

87564

Infectious agent detection by nucleic acid (DNA or RNA); Mycobacterium tuberculosis, rifampin resistance, amplified probe technique

Pathology and Laboratory

87594

Infectious agent detection by nucleic acid (DNA or RNA); Pneumocystis jirovecii, amplified probe technique

Pathology and Laboratory

87626

Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), separately reported high-risk types (eg, 16, 18, 31, 45, 51, 52) and high-risk pooled result(s)

Medicine Services and Procedures

90593

Chikungunya virus vaccine, recombinant, for intramuscular use

Medicine Services and Procedures

92137

Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina, including OCT angiography

Medicine Services and Procedures

93896

Vasoreactivity study performed with transcranial Doppler study of intracranial arteries, complete (List separately in addition to code for primary procedure)

Medicine Services and Procedures

93897

Emboli detection without intravenous microbubble injection performed with transcranial Doppler study of intracranial arteries, complete (List separately in addition to code for primary procedure)

Medicine Services and Procedures

93898

Venous-arterial shunt detection with intravenous microbubble injection performed with transcranial Doppler study of intracranial arteries, complete (List separately in addition to code for primary procedure)

Medicine Services and Procedures

96041

Medical genetics and genetic counseling services, each 30 minutes of total time provided by the genetic counselor on the date of the encounter

Medicine Services and Procedures

98000

Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 15 minutes must be met or exceeded.

Medicine Services and Procedures

98001

Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and low medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.

Medicine Services and Procedures

98002

Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and moderate medical decision making. When using total time on the date of the encounter for code selection, 45 minutes must be met or exceeded.

Medicine Services and Procedures

98003

Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and high medical decision making. When using total time on the date of the encounter for code selection, 60 minutes must be met or exceeded.

Medicine Services and Procedures

98004

Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 10 minutes must be met or exceeded.

Medicine Services and Procedures

98005

Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and low medical decision making. When using total time on the date of the encounter for code selection, 20 minutes must be met or exceeded.

Medicine Services and Procedures

98006

Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and moderate medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.

Medicine Services and Procedures

98007

Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and high medical decision making. When using total time on the date of the encounter for code selection, 40 minutes must be met or exceeded.

Medicine Services and Procedures

98008

Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, straightforward medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 15 minutes must be met or exceeded.

Speciality

CPT Code

Description

Medicine Services and Procedures

98009

Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, low medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.

Medicine Services and Procedures

98010

Synchronous audio-only visit for the evaluation and management of a new patient, which requires a

medically appropriate history and/or examination, moderate medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 45 minutes must be met or exceeded.

Medicine Services and Procedures

98011

Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, high medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 60 minutes must be met or exceeded.

Medicine Services and Procedures

98012

Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, straightforward medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 10 minutes must be exceeded.

Medicine Services and Procedures

98013

Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, low medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 20 minutes must be met or exceeded.

Medicine Services and Procedures

98014

Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, moderate medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.

Medicine Services and Procedures

98015

Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, high medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 40 minutes must be met or exceeded.

Medicine Services and Procedures

98016

Brief communication technology-based service (eg, virtual check-in) by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related evaluation and management service provided within the previous 7 days nor leading to an evaluation and management service or procedure within the next 24 hours or soonest available appointment, 5-10 minutes of medical discussion

Speciality

CPT

Code

2025 Description

2024 Description

Proprietary Laboratory Analyses

0095U

Eosinophilic esophagitis, 2 protein biomarkers (Eotaxin-3 [CCL26

{C-C motif chemokine ligand 26}] and Major Basic Protein [PRG2

{proteoglycan 2, pro eosinophil major basic protein}]), enzyme- linked immunosorbent assays (ELISA), specimen obtained by esophageal string test device, algorithm reported as probability of active or inactive eosinophilic esophagitis

Inflammation (eosinophilic esophagitis), ELISA analysis of eotaxin-3 (CCL26 [C-C motif chemokine ligand 26]) and major basic protein (PRG2 [proteoglycan 2, pro eosinophil major basic protein]), specimen obtained by swallowed nylon string, algorithm reported as predictive probability index for active eosinophilic esophagitis

Proprietary Laboratory Analyses

0356U

Oncology (bladder), 10 protein biomarkers (A1AT, ANG,

APOE, CA9, IL8, MMP9, MMP10, PAI1, SDC1 and VEGFA), by

immunoassays, urine, diagnostic algorithm, including patient’s age, race and gender, reported as a probability of harboring urothelial cancer

Oncology (bladder), analysis of 10 protein biomarkers (A1AT, ANG, APOE, CA9, IL8, MMP9, MMP10, PAI1, SDC1, and VEGFA)

by immunoassays, urine, algorithm reported as a probability of bladder cancer

Category III

0615T

Automated analysis of binocular eye movements without spatial calibration, including disconjugacy, saccades, and pupillary dynamics for the assessment of concussion, with interpretation and report

Eye-movement analysis without spatial calibration, with interpretation and report

Musculoskeletal System

21630

Radical resection of sternum

Radical resection of sternum;

Musculoskeletal System

25447

Arthroplasty, intercarpal or carpometacarpal joints; interposition (eg, tendon)

Arthroplasty, interposition, intercarpal or carpometacarpal joints

Respiratory System

25447

Obliteration of aortopulmonary septal defect, with cardiopulmonary bypass

Obliteration of aortopulmonary septal defect; with cardiopulmonary bypass

Genital Urinary System

51020

Cystotomy or cystostomy, with fulguration and/or insertion of radioactive material

Cystotomy or cystostomy; with fulguration and/or insertion of radioactive material

Genital Urinary System

58958

Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed, with pelvic lymphadenectomy and limited para-aortic lymphadenectomy

Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed; with pelvic lymphadenectomy and limited para-aortic lymphadenectomy

Pathology

81432

Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial

cancer, hereditary pancreatic cancer, hereditary prostate cancer), genomic sequence analysis panel, 5 or more genes, interrogation for sequence variants and copy number variants

Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer); genomic sequence analysis panel, must include sequencing of

at least 10 genes, always including BRCA1, BRCA2, CDH1, MLH1, MSH2, MSH6, PALB2, PTEN, STK11, and TP53

Pathology

81435

Hereditary colon cancer-related disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), genomic sequence analysis panel, 5 or more genes, interrogation for sequence variants and copy number variants

Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis); genomic sequence analysis panel, must include sequencing of at least 10 genes, including APC, BMPR1A, CDH1, MLH1, MSH2, MSH6, MUTYH, PTEN, SMAD4, and STK11

Pathology

81437

Hereditary neuroendocrine tumor-related disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, malignant pheochromocytoma or paraganglioma), genomic sequence analysis panel, 5 or more genes, interrogation for sequence variants and copy number variants

Hereditary neuroendocrine tumor disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, malignant pheochromocytoma or paraganglioma); genomic sequence analysis panel, must include sequencing of at least 6 genes, including MAX, SDHB, SDHC, SDHD, TMEM127, and VHL

Pathology

87624

Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45,

51, 52, 56, 58, 59, 68), pooled result

Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45,

51, 52, 56, 58, 59, 68)

Pathology

88387

Macroscopic examination, dissection, and preparation of tissue for non-microscopic analytical studies (eg, nucleic acid- based molecular studies), each tissue preparation (eg, a single lymph node)

Macroscopic examination, dissection, and preparation of tissue for non-microscopic analytical studies (eg, nucleic acid- based molecular studies); each tissue preparation (eg, a single lymph node)

Medicine

90661

Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use

Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use

Speciality

CPT

Code

2025 Description

2024 Description

Medicine

92132

Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), anterior segment, with interpretation and report, unilateral or bilateral

Scanning computerized ophthalmic diagnostic imaging, anterior segment, with interpretation and report, unilateral or bilateral

Medicine

92133

Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve

Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; optic nerve

Medicine

92134

Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina

Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina

Medicine

93656

Comprehensive electrophysiologic evaluation with transseptal catheterizations, insertion and repositioning of multiple electrode catheters, induction or attempted induction of an arrhythmia including left or right atrial pacing/recording, and intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation, including intracardiac electrophysiologic 3-dimensional mapping, intracardiac echocardiography with imaging supervision and interpretation, right ventricular pacing/recording, and His bundle recording, when performed

Comprehensive electrophysiologic evaluation including transseptal catheterizations, insertion and repositioning of multiple electrode catheters with intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation, including intracardiac electrophysiologic 3-dimensional mapping,

intracardiac echocardiography including imaging supervision and interpretation, induction or attempted induction of an arrhythmia including left or right atrial pacing/recording, right ventricular pacing/recording, and His bundle recording, when performed

Medicine

93893

Transcranial Doppler study of the intracranial arteries; venous- arterial shunt detection with intravenous microbubble injection

Transcranial Doppler study of the intracranial arteries; emboli detection with intravenous microbubble injection

Medicine

97811

Acupuncture, 1 or more needles; without electrical stimulation, each additional 15 minutes of personal one-on-one contact with the patient, with insertion of needle(s) (List separately in addition to code for primary procedure)

Acupuncture, 1 or more needles; without electrical stimulation, each additional 15 minutes of personal one-on-one contact with the patient, with re-insertion of needle(s) (List separately in addition to code for primary procedure)

Medicine

97814

Acupuncture, 1 or more needles; without electrical stimulation, each additional 15 minutes of personal one-on-one contact with the patient, with insertion of needle(s) (List separately in addition to code for primary procedure)

Acupuncture, 1 or more needles; without electrical stimulation, each additional 15 minutes of personal one-on-one contact with the patient, with re-insertion of needle(s) (List separately in addition to code for primary procedure)

Medicine

98960

Education and training for patient self-management by a nonphysician qualified health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; individual patient

Education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; individual patient

Medicine

98961

Education and training for patient self-management by a nonphysician qualified health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 2-4 patients

Education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 2-4 patients

Medicine

98962

Education and training for patient self-management by a nonphysician qualified health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 5-8 patients

Education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/ family) each 30 minutes; 5-8 patients

Medicine

98966

Telephone assessment and management service provided by a nonphysician qualified health care professional to an established patient, parent, or guardian not originating from a

related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion

Telephone assessment and management service provided by a qualified nonphysician health care professional to an established patient, parent, or guardian not originating from a

related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion

Medicine

98967

Telephone assessment and management service provided by a nonphysician qualified health care professional to an established patient, parent, or guardian not originating from a

related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion

Telephone assessment and management service provided by a qualified nonphysician health care professional to an established patient, parent, or guardian not originating from a

related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion

Medicine

98968

Telephone assessment and management service provided by a nonphysician qualified health care professional to an established patient, parent, or guardian not originating from a

related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion

Telephone assessment and management service provided by a qualified nonphysician health care professional to an established patient, parent, or guardian not originating from a

related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion

Medicine

98970

Nonphysician qualified health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes

Qualified nonphysician health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes

Medicine

98971

Nonphysician qualified health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes

Qualified nonphysician health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes

Medicine

98972

Nonphysician qualified health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes

Qualified nonphysician health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes

Speciality

CPT

Code

2025 Description

2024 Description

Medicine

64595

Revision or removal of peripheral, sacral, or gastric neurostimulator pulse generator or receiver, with detachable connection to electrode array

Revision or removal of peripheral or gastric neurostimulator pulse generator or receiver

Medicine

98975

Remote therapeutic monitoring (eg, therapy adherence, therapy response, digital therapeutic intervention); initial set-up and patient education on use of equipment

Remote therapeutic monitoring (eg, therapy adherence, therapy response); initial set-up and patient education on use of equipment

Medicine

98976

Remote therapeutic monitoring (eg, therapy adherence, therapy response, digital therapeutic intervention); device(s) supply

for data access or data transmissions to support monitoring of respiratory system, each 30 days

Remote therapeutic monitoring (eg, therapy adherence, therapy response); device(s) supply with scheduled (eg, daily) recording(s) and/or programmed alert(s) transmission to monitor respiratory system, each 30 days

Medicine

98977

Remote therapeutic monitoring (eg, therapy adherence, therapy response, digital therapeutic intervention); device(s) supply

for data access or data transmissions to support monitoring of musculoskeletal system, each 30 days

Remote therapeutic monitoring (eg, therapy adherence, therapy response); device(s) supply with scheduled (eg, daily) recording(s) and/or programmed alert(s) transmission to monitor musculoskeletal system, each 30 days

Medicine

98978

Remote therapeutic monitoring (eg, therapy adherence, therapy response, digital therapeutic intervention); device(s) supply

for data access or data transmissions to support monitoring of cognitive behavioral therapy, each 30 days

Remote therapeutic monitoring (eg, therapy adherence, therapy response); device(s) supply with scheduled (eg, daily) recording(s) and/or programmed alert(s) transmission to monitor cognitive behavioral therapy, each 30 days

Speciality

CPT Code

Description

Proprietary Laboratory Analyses

0346U

Beta Amyloid, Aß40 And Aß42 By Liquid Chromatography With Tandem Mass Spectrometry (Lc-Ms/Ms), Ratio, Plasma

Proprietary Laboratory Analyses

0352U

Infectious disease (bacterial vaginosis and vaginitis), multiplex amplified probe technique, for detection of bacterial vaginosis- associated bacteria (BVAB-2, Atopobium vaginae, and Megasphera type 1), algorithm reported as detected or not detected and separate detection of Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata/Candida krusei, and trichomonas vaginalis, vaginal-fluid specimen, each result reported as detected or not detected

Proprietary Laboratory Analyses

0380U

Drug Metabolism (Adverse Drug Reactions And Drug Response), Targeted Sequence Analysis, 20 Gene Variants And Cyp2D6 Deletion Or Duplication Analysis With Reported Genotype And Phenotype

Proprietary Laboratory Analyses

0428U

Oncology (Breast), Targeted Hybrid-Capture Genomic Sequence Analysis Panel, Circulating Tumor Dna (Ctdna) Analysis Of 56 Or More Genes, Interrogation For Sequence Variants, Gene Copy Number Amplifications, Gene Rearrangements, Microsatellite Instability, And Tumor Mutation Burden

Proprietary Laboratory Analyses

0448U

Oncology (Lung And Colon Cancer), Dna, Qualitative, Next-Generation Sequencing Detection Of Single-Nucleotide Variants And Deletions In Egfr And Kras Genes, Formalin-Fixed Paraffin-Embedded (Ffpe) Solid Tumor Samples, Reported As Presence Or Absence Of Targeted Mutation(S), With Recommended Therapeutic Options

Proprietary Laboratory Analyses

0456U

Autoimmune (Rheumatoid Arthritis), Next-Generation Sequencing (Ngs), Gene Expression Testing Of 19 Genes, Whole Blood, With Analysis Of Anti-Cyclic Citrullinated Peptides (Ccp) Levels, Combined With Sex, Patient Global Assessment, And Body Mass Index (Bmi), Algorithm Reported As A Score That Predicts Nonresponse To Tumor Necrosis Factor Inhibitor (Tnfi) Therapy

Category III

0398T

30 minutes face-to-face with patient/family

Category III

0500T

Infectious agent detection by nucleic acid (DNA or RNA), Human Papillomavirus (HPV) for five or more separately reported high-risk HPV types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) (ie, genotyping)

Category III

0537T

Chimeric antigen receptor T-cell (CAR-T) therapy; harvesting of blood-derived T lymphocytes for development of genetically modified autologous CAR-T cells, per day

Category III

0538T

Chimeric antigen receptor T-cell (CAR-T) therapy; preparation of blood-derived T lymphocytes for transportation (eg, cryopreservation, storage)

Category III

0539T

Chimeric antigen receptor T-cell (CAR-T) therapy; receipt and preparation of CAR-T cells for administration

Category III

0540T

Chimeric antigen receptor T-cell (CAR-T) therapy; CAR-T cell administration, autologous

Category III

0553T

Percutaneous transcatheter placement of iliac arteriovenous anastomosis implant, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention

Category III

0564T

Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported based on percent of cytotoxicity observed, a minimum of 14 drugs or drug combinations

Category III

0567T

Permanent fallopian tube occlusion with degradable biopolymer implant, transcervical approach, including transvaginal ultrasound

Category III

0568T

Introduction of mixture of saline and air for sonosalpingography to confirm occlusion of fallopian tubes, transcervical approach, including transvaginal ultrasound and pelvic ultrasound

Category III

0616T

Insertion of iris prosthesis, including suture fixation and repair or removal of iris, when performed; without removal of crystalline lens or intraocular lens, without insertion of intraocular lens

Category III

0617T

Insertion of iris prosthesis, including suture fixation and repair or removal of iris, when performed; with removal of crystalline lens and insertion of intraocular lens

Category III

0618T

Insertion of iris prosthesis, including suture fixation and repair or removal of iris, when performed; with secondary intraocular lens placement or intraocular lens exchange

Musculoskeletal System

15819

Cervicoplasty

Musculoskeletal System

21632

Radical resection of sternum; with mediastinal lymphadenectomy

Cardiovascular System

33471

Valvotomy, pulmonary valve, closed heart, via pulmonary

Cardiovascular System

33737

artery

Cardiovascular System

33813

Obliteration of aortopulmonary septal defect; without cardiopulmonary bypass

Speciality

CPT Code

Description

Digestive System

47802

U-tube hepaticoenterostomy

Digestive System

49203

Excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor 5 cm diameter or less

Digestive System

49204

Excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor 5.1-10.0 cm diameter

Digestive System

49205

Excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor greater than 10.0 cm diameter

Genital Urinary System

50135

Pyelotomy; complicated (eg, secondary operation, congenital kidney abnormality)

Genital Urinary System

51030

Cystotomy or cystostomy; with cryosurgical destruction of intravesical lesion

Genital Urinary System

54438

Replantation, penis, complete amputation including urethral repair

Genital Urinary System

58957

Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed

Genital Urinary System

0642T

Noncontact near-infrared spectroscopy studies of flap or wound (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation [StO2]); interpretation and report only, each flap or wound

Pathology

81433

Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer); duplication/deletion analysis panel, must include analyses for BRCA1, BRCA2, MLH1, MSH2, and STK11

Pathology

81436

Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis); duplication/deletion analysis panel, must include analysis of at least 5 genes, including MLH1, MSH2, EPCAM, SMAD4, and STK11

Pathology

81438

Hereditary neuroendocrine tumor disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, malignant pheochromocytoma or paraganglioma); duplication/deletion analysis panel, must include analyses for SDHB, SDHC, SDHD, and VHL

Pathology

86327

Immunoelectrophoresis; crossed (2-dimensional assay)

Pathology

86490

Skin test; coccidioidomycosis

Pathology

88388

Macroscopic examination, dissection, and preparation of tissue for non-microscopic analytical studies (eg, nucleic acid-based molecular studies); in conjunction with a touch imprint, intraoperative consultation, or frozen section, each tissue preparation (eg, a single lymph node) (List separately in addition to code for primary procedure)

Medicine

90630

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use

Medicine

90654

Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use

Medicine

93890

vasoreactivity study

Medicine

96003

Dynamic fine wire electromyography, during walking or other functional activities, 1 muscle

Medicine

96040

Medical genetics and genetic counseling services, each

E/M

99441

Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion

E/M

99442

Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion

E/M

99443

Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion

Speciality

HCPCS Code

Description

Durable Medical Equipment

E1803

Dynamic adjustable elbow extension only device, includes soft interface material

Durable Medical Equipment

E1804

Dynamic adjustable elbow flexion only device, includes soft interface material

Durable Medical Equipment

E1807

Dynamic adjustable wrist extension only device, includes soft interface material

Durable Medical Equipment

E1808

Dynamic adjustable wrist flexion only device, includes soft interface material

Durable Medical Equipment

E1813

Dynamic adjustable knee extension only device, includes soft interface material

Durable Medical Equipment

E1814

Dynamic adjustable knee flexion only device, includes soft interface material

Durable Medical Equipment

E1822

Dynamic adjustable ankle extension only device, includes soft interface material

Durable Medical Equipment

E1823

Dynamic adjustable ankle flexion only device, includes soft interface material

Durable Medical Equipment

E1826

Dynamic adjustable finger extension only device, includes soft interface material

Durable Medical Equipment

E1827

Dynamic adjustable finger flexion only device, includes soft interface material

Durable Medical Equipment

E1828

Dynamic adjustable toe extension only device, includes soft interface material

Durable Medical Equipment

E1829

Dynamic adjustable toe flexion only device, includes soft interface material

Non Oral Medications

J0601

Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)

Non Oral Medications

J0602

Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)

Non Oral Medications

J0603

Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)

Non Oral Medications

J0605

Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)

Non Oral Medications

J0607

Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)

Non Oral Medications

J0608

Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)

Non Oral Medications

J0609

Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)

Non Oral Medications

J0615

Calcium acetate, oral, 23 mg (for esrd on dialysis)

Non Oral Medications

J0666

Injection, bupivacaine liposome, 1 mg

Non Oral Medications

J0870

Injection, imetelstat, 1 mg

Non Oral Medications

J0901

Vadadustat, oral, 1 mg (for esrd on dialysis)

Non Oral Medications

J1307

Injection, crovalimab-akkz, 10 mg

Non Oral Medications

J1414

Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose

Non Oral Medications

J1552

Injection, immune globulin (alyglo), 500 mg

Non Oral Medications

J2290

Injection, nafcillin sodium, 20 mg

Non Oral Medications

J2472

Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg

Non Oral Medications

J2802

Injection, romiplostim, 1 microgram

Non Oral Medications

J3392

Injection, exagamglogene autotemcel, per treatment

Non Oral Medications

J7514

Mycophenolate mofetil (myhibbin), oral suspension, 100 mg

Non Oral Medications

J7601

Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg

Non Oral Medications

J9026

Injection, tarlatamab-dlle, 1 mg

Non Oral Medications

J9028

Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram

Non Oral Medications

J9076

Injection, cyclophosphamide (baxter), 5 mg

Non Oral Medications

J9292

Injection, pemetrexed (avyxa), not therapeutically equivalent to j9305, 10 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q0521

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q5139

Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg

Speciality

HCPCS Code

Description

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q5140

Injection, adalimumab-fkjp, biosimilar, 1 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q5141

Injection, adalimumab-aaty, biosimilar, 1 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q5142

Injection, adalimumab-ryvk biosimilar, 1 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q5143

Injection, adalimumab-adbm, biosimilar, 1 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q5144

Injection, adalimumab-aacf (idacio), biosimilar, 1 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q5145

Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q5146

Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q9996

Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q9997

Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q9998

Injection, ustekinumab-aekn (selarsdi), 1 mg

Speciality

HCPCS Code

Description

Tuberculosis Codes

TB

Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes

Durable Medical Equipment

E1800

Dynamic adjustable elbow extension and flexion device, includes soft interface material

Durable Medical Equipment

E1805

Dynamic adjustable wrist extension and flexion device, includes soft interface material

Durable Medical Equipment

E1810

Dynamic adjustable knee extension and flexion device, includes soft interface material

Durable Medical Equipment

E1815

Dynamic adjustable ankle extension and flexion device, includes soft interface material

Durable Medical Equipment

E1825

Dynamic adjustable finger extension and flexion device, includes soft interface material

Durable Medical Equipment

E1830

Dynamic adjustable toe extension and flexion device, includes soft interface material

Non Oral Medicaltions

J2468

Injection, palonosetron hydrochloride (posfrea), 25 micrograms

Non Oral Medicaltions

J9033

Injection, bendamustine hydrochloride, 1 mg

Non Oral Medicaltions

J9072

Injection, cyclophosphamide (avyxa), 5 mg

Orthodics or Prothestics

L8720

External lower extremity sensory prosthetic device, cutaneous stimulation of mechanoreceptors proximal to the ankle, per leg

Speciality

HCPCS

Code

Description

Non Oral Medications

JG

Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes

Non Oral Medications

J0135

Injection, adalimumab, 20 mg

Non Oral Medications

J0570

Buprenorphine implant, 74.2 mg

Non Oral Medications

J2796

Injection, romiplostim, 10 micrograms

Non Oral Medications

J2806

Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms

Non Oral Medications

J9058

Injection, bendamustine hydrochloride (apotex), 1 mg

Non Oral Medications

J9059

Injection, bendamustine hydrochloride (baxter), 1 mg

Non Oral Medications

J9259

Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q0516

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q0517

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q0518

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q0519

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q0520

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q5131

Injection, adalimumab-aacf (idacio), biosimilar, 20 mg

Drugs, biologicals & medical equipment not identified as HCPCS level II codes

Q5132

Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg

Speciality

ICD-10

Code

New Description

Old Description

Certain infectious and parasitic diseases

A77.41

Ehrlichiosis chaffeensis [E. chaffeensis]

Ehrlichiosis chafeensis [E. chafeensis]

Mental, Behavioral and Neurodevelopmental disorders

F98.21

Rumination disorder of infancy and childhood

Rumination disorder of infancy

Diseases of the nervous system

G93.42

Megalencephalic leukoencephalopathy with subcortical cysts

Megaloencephalic leukoencephalopathy with subcortical cysts

Diseases of the eye and adnexa

H44.2A3

Degenerative myopia with choroidal neovascularization, bilateral

Degenerative myopia with choroidal neovascularization, bilateral eye

Diseases of the eye and adnexa

H44.2B3

Degenerative myopia with macular hole, bilateral

Degenerative myopia with macular hole, bilateral eye

Diseases of the eye and adnexa

H44.2C3

Degenerative myopia with retinal detachment, bilateral

Degenerative myopia with retinal detachment, bilateral eye

Diseases of the eye and adnexa

H44.2D3

Degenerative myopia with foveoschisis, bilateral

Degenerative myopia with foveoschisis, bilateral eye

Diseases of the eye and adnexa

H44.2E3

Degenerative myopia with other maculopathy, bilateral

Degenerative myopia with other maculopathy, bilateral

eye

Diseases of the circulatory system

I26.93

Single subsegmental thrombotic pulmonary embolism without acute or pulmonale

Single subsegmental pulmonary embolism without acute or pulmonale

Diseases of the circulatory system

I26.94

Multiple subsegmental thrombotic pulmonary emboli without acute or pulmonale

Multiple subsegmental pulmonary emboli without acute or pulmonale

Diseases of the digestive system

K58.9

Irritable bowel syndrome, unspecified

Irritable bowel syndrome without diarrhea

Congenital malformations, deformations and chromosomal abnormalities

Q13.81

Rieger anomaly

Rieger’s anomaly

Factors influencing health status and contact with health services

Z68.54

Body mass index [BMI] pediatric, 95th percentile for age

to less than 120% of the 95th percentile for age

Body mass index [BMI] pediatric, greater than or equal to 95th percentile for age

System

ICD-10 Code

Description

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C81.0A

Nodular lymphocyte predominant Hodgkin lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C81.1A

Nodular sclerosis Hodgkin lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C81.2A

Mixed cellularity Hodgkin lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C81.3A

Lymphocyte depleted Hodgkin lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C81.4A

Lymphocyte-rich Hodgkin lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C81.7A

Other Hodgkin lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C81.9A

Hodgkin lymphoma, unspecified, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C82.0A

Follicular lymphoma grade I, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C82.1A

Follicular lymphoma grade II, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C82.2A

Follicular lymphoma grade III, unspecified, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C82.3A

Follicular lymphoma grade IIIa, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C82.4A

Follicular lymphoma grade IIIb, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C82.5A

Diffuse follicle center lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C82.6A

Cutaneous follicle center lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C82.8A

Other types of follicular lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C82.9A

Follicular lymphoma, unspecified, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C83.0A

Small cell B-cell lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C83.1A

Mantle cell lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C83.390

Primary central nervous system lymphoma

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C83.398

Diffuse large B-cell lymphoma of other extranodal and solid organ Sites

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C83.3A

Diffuse large B-cell lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C83.5A

Lymphoblastic (diffuse) lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C83.7A

Burkitt lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C83.8A

Other non-follicular lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C83.9A

Non-follicular (diffuse) lymphoma, unspecified, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C84.0A

Mycosis fungoides, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C84.1A

Sezary disease, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C84.4A

Peripheral T-cell lymphoma, not elsewhere classified, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C84.6A

Anaplastic large cell lymphoma, ALK-positive, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C84.7B

Anaplastic large cell lymphoma, ALK-negative, in remission

System

ICD-10 Code

Description

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C84.9A

Mature T/NK-cell lymphomas, unspecified, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C84.AA

Cutaneous T-cell lymphoma, unspecified, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C84.ZA

Other mature T/NK-cell lymphomas, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C85.1A

Unspecified B-cell lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C85.2A

Mediastinal (thymic) large B-cell lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C85.8A

Other specified types of non-Hodgkin lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C85.9A

Non-Hodgkin lymphoma, unspecified, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.00

Extranodal NK/T-cell lymphoma, nasal type not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.01

Extranodal NK/T-cell lymphoma, nasal type, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.10

Hepatosplenic T-cell lymphoma not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.11

Hepatosplenic T-cell lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.20

Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.21

Enteropathy-type (intestinal) T-cell lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.30

Subcutaneous panniculitis-like T-cell lymphoma not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.31

Subcutaneous panniculitis-like T-cell lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.40

Blastic NK-cell lymphoma not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.41

Blastic NK-cell lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.50

Angioimmunoblastic T-cell lymphoma not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.51

Angioimmunoblastic T-cell lymphoma, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.60

Primary cutaneous CD30-positive T-cell proliferations not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.61

Primary cutaneous CD30-positive T-cell proliferations, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.00

Waldenstrom macroglobulinemia not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.01

Waldenstrom macroglobulinemia, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.20

Heavy chain disease not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.21

Heavy chain disease, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.30

Immunoproliferative small intestinal disease not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.31

Immunoproliferative small intestinal disease, in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.40

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.41

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], in remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.80

Other malignant immunoproliferative diseases not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.81

Other malignant immunoproliferative diseases, in remission

System

ICD-10 Code

Description

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.90

Malignant immunoproliferative disease, unspecified not having achieved remission

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.91

Malignant immunoproliferative disease, unspecified, in remission

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

D61.03

Fanconi anemia

Endocrine, nutritional and metabolic diseases

E10.A0

Type 1 diabetes mellitus, presymptomatic, unspecified

Endocrine, nutritional and metabolic diseases

E10.A1

Type 1 diabetes mellitus, presymptomatic, Stage 1

Endocrine, nutritional and metabolic diseases

E10.A2

Type 1 diabetes mellitus, presymptomatic, Stage 2

Endocrine, nutritional and metabolic diseases

E16.A1

Hypoglycemia level 1

Endocrine, nutritional and metabolic diseases

E16.A2

Hypoglycemia level 2

Endocrine, nutritional and metabolic diseases

E16.A3

Hypoglycemia level 3

Endocrine, nutritional and metabolic diseases

E34.00

Carcinoid syndrome, unspecified

Endocrine, nutritional and metabolic diseases

E34.01

Carcinoid heart syndrome

Endocrine, nutritional and metabolic diseases

E34.09

Other carcinoid syndrome

Endocrine, nutritional and metabolic diseases

E66.811

Obesity, class 1

Endocrine, nutritional and metabolic diseases

E66.812

Obesity, class 2

Endocrine, nutritional and metabolic diseases

E66.813

Obesity, class 3

Endocrine, nutritional and metabolic diseases

E66.89

Other obesity not elsewhere classified

Endocrine, nutritional and metabolic diseases

E74.820

SLC13A5 Citrate Transporter Disorder

Endocrine, nutritional and metabolic diseases

E74.829

Other disorders of citrate metabolism

Endocrine, nutritional and metabolic diseases

E88.82

Obesity due to disruption of MC4R pathway

Mental, behavioral and neurodevelopmental disorders

f50.010

Anorexia nervosa, restricting type, mild

Mental, behavioral and neurodevelopmental disorders

f50.011

Anorexia nervosa, restricting type, moderate

Mental, behavioral and neurodevelopmental disorders

f50.012

Anorexia nervosa, restricting type, severe

Mental, behavioral and neurodevelopmental disorders

f50.013

Anorexia nervosa, restricting type, extreme

Mental, behavioral and neurodevelopmental disorders

f50.014

Anorexia nervosa, restricting type, in remission

Mental, behavioral and neurodevelopmental disorders

f50.019

Anorexia nervosa, restricting type, unspecified

Mental, behavioral and neurodevelopmental disorders

f50.020

Anorexia nervosa, binge eating/purging type, mild

Mental, behavioral and neurodevelopmental disorders

f50.021

Anorexia nervosa, binge eating/purging type, moderate

Mental, behavioral and neurodevelopmental disorders

f50.022

Anorexia nervosa, binge eating/purging type, severe

Mental, behavioral and neurodevelopmental disorders

f50.023

Anorexia nervosa, binge eating/purging type, extreme

Mental, behavioral and neurodevelopmental disorders

f50.024

Anorexia nervosa, binge eating/purging type, in remission

Mental, behavioral and neurodevelopmental disorders

f50.029

Anorexia nervosa, binge eating/purging type, unspecified

Mental, behavioral and neurodevelopmental disorders

f50.20

Bulimia nervosa, unspecified

Mental, behavioral and neurodevelopmental disorders

f50.21

Bulimia nervosa, mild

Mental, behavioral and neurodevelopmental disorders

f50.22

Bulimia nervosa, moderate

System

ICD-10 Code

Description

Mental, behavioral and neurodevelopmental disorders

f50.23

Bulimia nervosa, severe

Mental, behavioral and neurodevelopmental disorders

f50.24

Bulimia nervosa, extreme

Mental, behavioral and neurodevelopmental disorders

f50.25

Bulimia nervosa, in remission

Mental, behavioral and neurodevelopmental disorders

f50.810

Binge eating disorder, mild

Mental, behavioral and neurodevelopmental disorders

f50.811

Binge eating disorder, moderate

Mental, behavioral and neurodevelopmental disorders

f50.812

Binge eating disorder, severe

Mental, behavioral and neurodevelopmental disorders

f50.813

Binge eating disorder, extreme

Mental, behavioral and neurodevelopmental disorders

f50.814

Binge eating disorder, in remission

Mental, behavioral and neurodevelopmental disorders

f50.83

Pica in adults

Mental, behavioral and neurodevelopmental disorders

f50.84

Rumination disorder in adults

Diseases of the nervous system

G40.841

KCNQ2-related epilepsy, not intractable, with status epilepticus

Diseases of the nervous system

G40.842

KCNQ2-related epilepsy, not intractable, without status epilepticus

Diseases of the nervous system

G40.843

KCNQ2-related epilepsy, intractable, with status epilepticus

Diseases of the nervous system

G40.844

KCNQ2-related epilepsy, intractable, without status epilepticus

Diseases of the nervous system

G90.81

Serotonin syndrome

Diseases of the nervous system

G90.89

Other disorders of autonomic nervous system

Diseases of the nervous system

G93.45

Developmental and epileptic encephalopathy

Diseases of the circulatory system

I26.03

Cement embolism of pulmonary artery with acute cor pulmonale

Diseases of the circulatory system

I26.04

Fat embolism of pulmonary artery with acute cor pulmonale

Diseases of the circulatory system

I26.95

Cement embolism of pulmonary artery without acute cor pulmonale

Diseases of the circulatory system

I26.96

Fat embolism of pulmonary artery without acute cor pulmonale

Diseases of the circulatory system

H578A9

Foreign body sensation, unspecified eye

Diseases of the respiratory system

J34.8200

Internal nasal valve collapse, unspecified

Diseases of the respiratory system

J34.8201

Internal nasal valve collapse, static

Diseases of the respiratory system

J34.8202

Internal nasal valve collapse, dynamic

Diseases of the respiratory system

J34.8210

External nasal valve collapse, unspecified

Diseases of the respiratory system

J34.8211

External nasal valve collapse, static

Diseases of the respiratory system

J34.8212

External nasal valve collapse, dynamic

Diseases of the respiratory system

J34.829

Nasal valve collapse, unspecified

Diseases of the digestive system

K60.30

Anal fistula, unspecified

Diseases of the digestive system

K60.311

Anal fistula, simple, initial

Diseases of the digestive system

K60.312

Anal fistula, simple, persistent

Diseases of the digestive system

K60.313

Anal fistula, simple, recurrent

Diseases of the digestive system

K60.319

Anal fistula, simple, unspecified

Diseases of the digestive system

K60.321

Anal fistula, complex, initial

Diseases of the digestive system

K60.322

Anal fistula, complex, persistent

Diseases of the digestive system

K60.323

Anal fistula, complex, recurrent

System

ICD-10 Code

Description

Diseases of the digestive system

K60.329

Anal fistula, complex, unspecified

Diseases of the digestive system

K60.40

Rectal fistula, unspecified

Diseases of the digestive system

K60.411

Rectal fistula, simple, initial

Diseases of the digestive system

K60.412

Rectal fistula, simple, persistent

Diseases of the digestive system

K60.413

Rectal fistula, simple, recurrent

Diseases of the digestive system

K60.419

Rectal fistula, simple, unspecified

Diseases of the digestive system

K60.421

Rectal fistula, complex, initial

Diseases of the digestive system

K60.422

Rectal fistula, complex, persistent

Diseases of the digestive system

K60.423

Rectal fistula, complex, recurrent

Diseases of the digestive system

K60.429

Rectal fistula, complex, unspecified

Diseases of the digestive system

K60.50

Anorectal fistula, unspecified

Diseases of the digestive system

K60.511

Anorectal fistula, simple, initial

Diseases of the digestive system

K60.512

Anorectal fistula, simple, persistent

Diseases of the digestive system

K60.513

Anorectal fistula, simple, recurrent

Diseases of the digestive system

K60.519

Anorectal fistula, simple, unspecified

Diseases of the digestive system

K60.521

Anorectal fistula, complex, initial

Diseases of the digestive system

K60.522

Anorectal fistula, complex, persistent

Diseases of the digestive system

K60.523

Anorectal fistula, complex, recurrent

Diseases of the digestive system

K60.529

Anorectal fistula, complex, unspecified

Diseases of the skin and subcutaneous tissue

L29.81

Cholestatic pruritus

Diseases of the skin and subcutaneous tissue

L29.89

Other pruritus

Diseases of the skin and subcutaneous tissue

L66.10

Lichen planopilaris, unspecified

Diseases of the skin and subcutaneous tissue

L66.11

Classic lichen planopilaris

Diseases of the skin and subcutaneous tissue

L66.12

Frontal fibrosing alopecia

Diseases of the skin and subcutaneous tissue

L66.19

Other lichen planopilaris

Diseases of the skin and subcutaneous tissue

L66.81

Central centrifugal cicatricial alopecia

Diseases of the skin and subcutaneous tissue

L66.89

Other cicatricial alopecia

Diseases of the musculoskeletal system and connective tissue

M51.360

Other intervertebral disc degeneration, lumbar region with discogenic back pain only

Diseases of the musculoskeletal system and connective tissue

M51.361

Other intervertebral disc degeneration, lumbar region with lower extremity pain only

Diseases of the musculoskeletal system and connective tissue

M51.362

Other intervertebral disc degeneration, lumbar region with discogenic back pain and lower extremity pain

Diseases of the musculoskeletal system and connective tissue

M51.369

Other intervertebral disc degeneration, lumbar region without mention of lumbar back pain or lower extremity pain

Diseases of the musculoskeletal system and connective tissue

M51.370

Other intervertebral disc degeneration, lumbosacral region with discogenic back pain only

Diseases of the musculoskeletal system and connective tissue

M51.371

Other intervertebral disc degeneration, lumbosacral region with lower extremity pain only

Diseases of the musculoskeletal system and connective tissue

M51.372

Other intervertebral disc degeneration, lumbosacral region with discogenic back pain and lower extremity pain

Diseases of the musculoskeletal system and connective tissue

M51.379

Other intervertebral disc degeneration, lumbosacral region without mention of lumbar back pain or lower extremity pain

Diseases of the musculoskeletal system and connective tissue

M62.85

Dysfunction of the multifidus muscles, lumbar region

Diseases of the musculoskeletal system and connective tissue

M65.90

Unspecified synovitis and tenosynovitis, unspecified site

Diseases of the musculoskeletal system and connective tissue

M65.911

Unspecified synovitis and tenosynovitis, right shoulder

Diseases of the musculoskeletal system and connective tissue

M65.912

Unspecified synovitis and tenosynovitis, left shoulder

System

ICD-10 Code

Description

Diseases of the musculoskeletal system and connective tissue

M65.919

Unspecified synovitis and tenosynovitis, unspecified shoulder

Diseases of the musculoskeletal system and connective tissue

M65.921

Unspecified synovitis and tenosynovitis, right upper arm

Diseases of the musculoskeletal system and connective tissue

M65.922

Unspecified synovitis and tenosynovitis, left upper arm

Diseases of the musculoskeletal system and connective tissue

M65.929

Unspecified synovitis and tenosynovitis, unspecified upper arm

Diseases of the musculoskeletal system and connective tissue

M65.931

Unspecified synovitis and tenosynovitis, right forearm

Diseases of the musculoskeletal system and connective tissue

M65.932

Unspecified synovitis and tenosynovitis, left forearm

Diseases of the musculoskeletal system and connective tissue

M65.939

Unspecified synovitis and tenosynovitis, unspecified forearm

Diseases of the musculoskeletal system and connective tissue

M65.941

Unspecified synovitis and tenosynovitis, right hand

Diseases of the musculoskeletal system and connective tissue

M65.942

Unspecified synovitis and tenosynovitis, left hand

Diseases of the musculoskeletal system and connective tissue

M65.949

Unspecified synovitis and tenosynovitis, unspecified hand

Diseases of the musculoskeletal system and connective tissue

M65.951

Unspecified synovitis and tenosynovitis, right thigh

Diseases of the musculoskeletal system and connective tissue

M65.952

Unspecified synovitis and tenosynovitis, left thigh

Diseases of the musculoskeletal system and connective tissue

M65.959

Unspecified synovitis and tenosynovitis, unspecified thigh

Diseases of the musculoskeletal system and connective tissue

M65.961

Unspecified synovitis and tenosynovitis, right lower leg

Diseases of the musculoskeletal system and connective tissue

M65.962

Unspecified synovitis and tenosynovitis, left lower leg

Diseases of the musculoskeletal system and connective tissue

M65.969

Unspecified synovitis and tenosynovitis, unspecified lower leg

Diseases of the musculoskeletal system and connective tissue

M65.971

Unspecified synovitis and tenosynovitis, right ankle and foot

Diseases of the musculoskeletal system and connective tissue

M65.972

Unspecified synovitis and tenosynovitis, left ankle and foot

Diseases of the musculoskeletal system and connective tissue

M65.979

Unspecified synovitis and tenosynovitis, unspecified ankle and foot

Diseases of the musculoskeletal system and connective tissue

M65.98

Unspecified synovitis and tenosynovitis, other site

Diseases of the musculoskeletal system and connective tissue

M65.99

Unspecified synovitis and tenosynovitis, multiple sites

Congenital malformations, deformations and chromosomal abnormalities

Q23.81

Bicuspid aortic valve

Congenital malformations, deformations and chromosomal abnormalities

Q23.82

Congenital mitral valve cleft leaflet

Congenital malformations, deformations and chromosomal abnormalities

Q23.88

Other congenital malformations of aortic and mitral valves

Congenital malformations, deformations and chromosomal abnormalities

Q87.86

Kleefstra syndrome

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

R41.85

Anosognosia

Injury, poisoning and certain other consequences of external causes

T45.AX1A

Poisoning by immune checkpoint inhibitors and immunostimulantd foot drugs, accidental (unintentional), initial encounter

Injury, poisoning and certain other consequences of external causes

T45.AX1D

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter

System

ICD-10 Code

Description

Injury, poisoning and certain other consequences of external causes

T45.AX1S

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela

Injury, poisoning and certain other consequences of external causes

T45.AX2A

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter

Injury, poisoning and certain other consequences of external causes

T45.AX2D

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter

Injury, poisoning and certain other consequences of external causes

T45.AX2S

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela

Injury, poisoning and certain other consequences of external causes

T45.AX3A

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter

Injury, poisoning and certain other consequences of external causes

T45.AX3D

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter

Injury, poisoning and certain other consequences of external causes

T45.AX3S

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela

Injury, poisoning and certain other consequences of external causes

T45.AX4A

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter

Injury, poisoning and certain other consequences of external causes

T45.AX4D

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter

Injury, poisoning and certain other consequences of external causes

T45.AX4S

Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela

Injury, poisoning and certain other consequences of external causes

T45.AX5A

Adverse effect of immune checkpoint inhibitors and immunostim ulant drugs, initial encounter

Injury, poisoning and certain other consequences of external causes

T45.AX5D

Adverse effect of immune checkpoint inhibitors and immunostim ulant drugs, subsequent encounter

Injury, poisoning and certain other consequences of external causes

T45.AX5S

Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela

Injury, poisoning and certain other consequences of external causes

T45.AX6A

Underdosing of immune checkpoint inhibitors and immunostimulant drugs, initial encounter

Injury, poisoning and certain other consequences of external causes

T45.AX6D

Underdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter

Injury, poisoning and certain other consequences of external causes

T45.AX6S

Underdosing of immune checkpoint inhibitors and immunostimulant drugs, sequela

Injury, poisoning and certain other consequences of external causes

T81.320A

Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure, initial encounter

Injury, poisoning and certain other consequences of external causes

T81.320D

Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure, subsequent encounter

Injury, poisoning and certain other consequences of external causes

T81.320S

Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure, sequela

Injury, poisoning and certain other consequences of external causes

T81.321A

Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia, initial encounter

Injury, poisoning and certain other consequences of external causes

T81.321D

Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia, subsequent encounter

Injury, poisoning and certain other consequences of external causes

T81.321S

Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia, sequela

Injury, poisoning and certain other consequences of external causes

T81.328A

Disruption or dehiscence of closure of other specified internal operation (surgical) wound, initial encounter

Injury, poisoning and certain other consequences of external causes

T81.328D

Disruption or dehiscence of closure of other specified internal operation (surgical) wound, subsequent encounter

Injury, poisoning and certain other consequences of external causes

T81.328S

Disruption or dehiscence of closure of other specified internal operation (surgical) wound, sequela

Injury, poisoning and certain other consequences of external causes

T81.329A

Deep disruption or dehiscence of operation wound, unspecified, initial encounter

Injury, poisoning and certain other consequences of external causes

T81.329D

Deep disruption or dehiscence of operation wound, unspecified, subsequent encounter

Injury, poisoning and certain other consequences of external causes

T81.329S

Deep disruption or dehiscence of operation wound, unspecified, sequela

Factors influencing health status and contact with health services

Z15.1

Genetic susceptibility to epilepsy and neurodevelopmental disorders

Factors influencing health status and contact with health services

Z15.2

Genetic susceptibility to obesity

System

ICD-10 Code

Description

Factors influencing health status and contact with health services

Z17.21

Progesterone receptor positive status

Factors influencing health status and contact with health services

Z17.22

Progesterone receptor negative status

Factors influencing health status and contact with health services

Z17.31

Human epidermal growth factor receptor 2 positive status

Factors influencing health status and contact with health services

Z17.32

Human epidermal growth factor receptor 2 negative status

Factors influencing health status and contact with health services

Z17.410

Hormone receptor positive with human epidermal growth factor receptor 2 positive status

Factors influencing health status and contact with health services

Z17.411

Hormone receptor positive with human epidermal growth factor receptor 2 negative status

Factors influencing health status and contact with health services

Z17.420

Hormone receptor negative with human epidermal growth factor receptor 2 positive status

Factors influencing health status and contact with health services

Z17.421

Hormone receptor negative with human epidermal growth factor receptor 2 negative status

Factors influencing health status and contact with health services

Z51.A

Encounter for sepsis aftercare

Factors influencing health status and contact with health services

Z59.71

Insufficient health insurance coverage

Factors influencing health status and contact with health services

Z59.72

Insufficient welfare support

Factors influencing health status and contact with health services

Z67.A1

Duffy null

Factors influencing health status and contact with health services

Z67.A2

Duffy a positive

Factors influencing health status and contact with health services

Z67.A3

Duffy b positive

Factors influencing health status and contact with health services

Z67.A4

Duffy a and b positive

Factors influencing health status and contact with health services

Z68.55

Body mass index [BMI] pediatric, 120% of the 95th percentile for age to less than 140% of the 95th percentile for age

Factors influencing health status and contact with health services

Z68.56

Body mass index [BMI] pediatric, greater than or equal to 140% of the 95th percentile for age

Factors influencing health status and contact with health services

Z83.72

Family history of familial adenomatous polyposis

Factors influencing health status and contact with health services

Z86.0100

Personal history of colon polyps, unspecified

Factors influencing health status and contact with health services

Z86.0101

Personal history of adenomatous and serrated colon polyps

Factors influencing health status and contact with health services

Z86.0102

Personal history of hyperplastic colon polyps

Factors influencing health status and contact with health services

Z86.0109

Personal history of other colon polyps

Factors influencing health status and contact with health services

Z92.26

Personal history of immune checkpoint inhibitor therapy

System

ICD-10 Code

Description

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C83.39

Diffuse large B-cell lymphoma, extranodal and solid organ sites

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.0

Extranodal NK/T-cell lymphoma, nasal type

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.1

Hepatosplenic T-cell lymphoma

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.2

Enteropathy-type (intestinal) T-cell lymphoma

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.3

Subcutaneous panniculitis-like T-cell lymphoma

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.4

Blastic NK-cell lymphoma

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.5

Angioimmunoblastic T-cell lymphoma

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C86.6

Primary cutaneous CD30-positive T-cell proliferations

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.0

Waldenstrom macroglobulinemia

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.2

Heavy chain disease

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.3

Immunoproliferative small intestinal disease

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.4

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.8

Other malignant immunoproliferative diseases

Malignant neoplasms of lymphoid, hematopoietic and related tissue

C88.9

Malignant immunoproliferative disease, unspecified

Endocrine, nutritional and metabolic diseases

E34.0

Carcinoid syndrome

Endocrine, nutritional and metabolic diseases

E66.8

Other obesity

Mental, behavioral and neurodevelopmental disorders

F50.01

Anorexia nervosa, restricting type

Mental, behavioral and neurodevelopmental disorders

F50.02

Anorexia nervosa, binge eating/purging type

Mental, behavioral and neurodevelopmental disorders

F50.2

Bulimia nervosa

Mental, behavioral and neurodevelopmental disorders

F50.81

Binge eating disorder

Diseases of the nervous system

G90.8

Other disorders of autonomic nervous system

Diseases of the digestive system

K60.3

Anal fistula

Diseases of the digestive system

K60.4

Rectal fistula

Diseases of the digestive system

K60.5

Anorectal fistula

Diseases of the skin and subcutaneous tissue

L29.8

Other pruritus

Diseases of the skin and subcutaneous tissue

L66.1

Lichen planopilaris

Diseases of the skin and subcutaneous tissue

L66.8

Other cicatricial alopecia

System

ICD-10 Code

Description

Diseases of the musculoskeletal system and connective tissue

M51.36

Other intervertebral disc degeneration, lumbar region

Diseases of the musculoskeletal system and connective tissue

M51.37

Other intervertebral disc degeneration, lumbosacral region

Diseases of the musculoskeletal system and connective tissue

M65.9

Synovitis and tenosynovitis, unspecified

Congenital malformations, deformations and chromosomal abnormalities

Q23.8

Other congenital malformations of aortic and mitral valves

Injury, poisoning and certain other consequences of external causes

T81.32XA

Disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter

Injury, poisoning and certain other consequences of external causes

T81.32XD

Disruption of internal operation (surgical) wound, not elsewhere classified, subsequent encounter

Injury, poisoning and certain other consequences of external causes

T81.32XS

Disruption of internal operation (surgical) wound, not elsewhere classified, sequela

Factors influencing health status and contact with health services

Z59.7

Insufficient social insurance and welfare support

Factors influencing health status and contact with health services

Z86.010

Personal history of colonic polyps